Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Apollo Hospital Ent
Join Channel
Consolidated Standalone

Apollo Hospital Ent.

₹7262.3 20.3 | 0.3%

Market Cap ₹104421 Cr.

Stock P/E 113.9

P/B 13.9

Current Price ₹7262.3

Book Value ₹ 521.1

Face Value 5

52W High ₹7545.1

Dividend Yield 0.22%

52W Low ₹ 5618.3

Edit Ratio

Apollo Hospital Ent. Research see more...

Overview Inc. Year: 1979Industry: Hospital & Healthcare Services

Apollo Hospitals Enterprise Limited is an India-based organisation, that is engaged in providing complete health facility offerings. The Company affords and sells pharma and well being products via a community of pharmacies. The predominant activities of the Company encompass the operation of multidisciplinary non-public hospitals, clinics and pharmacies. The Company operates via two segments: Healthcare and Retail Pharmacy. The Healthcare section represents hospitals and primarily medical institution-based pharmacies. The Retail Pharmacy section represents the commercial enterprise of procurement and distribution of pharmaceutical, FMCG and private label merchandise. The Company has approximately 10209 beds throughout about 71 Hospitals, 24118 pharmacies in 20 states and four union territories.

Read More..

Apollo Hospital Ent. Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Apollo Hospital Ent. Quarterly Results

#(Fig in Cr.) Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 3796 4251 4264 4302 4418 4847 4851 4944 5086 5589
Other Income 16 23 35 16 28 22 28 28 37 38
Total Income 3812 4274 4299 4319 4446 4869 4878 4972 5123 5628
Total Expenditure 3305 3686 3758 3814 3909 4219 4237 4303 4411 4774
Operating Profit 507 588 541 505 537 650 642 669 712 854
Interest 93 93 100 95 106 111 113 119 116 118
Depreciation 148 155 153 159 167 163 167 190 177 185
Exceptional Income / Expenses 0 0 0 0 0 2 0 0 0 0
Profit Before Tax 266 340 287 250 264 377 362 360 419 552
Provision for Tax -70 114 104 108 97 130 109 110 115 162
Profit After Tax 336 226 184 142 168 247 253 250 304 390
Adjustments -19 -22 -30 3 -1 -14 -8 4 1 -11
Profit After Adjustments 317 204 154 145 167 233 245 254 305 379
Adjusted Earnings Per Share 22.1 14.2 10.7 10 11.6 16.2 17.1 17.6 21.2 26.3

Apollo Hospital Ent. Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 4384 5178 6215 7256 8243 9617 11247 10560 14663 16613 19059 20470
Other Income 21 37 53 44 34 32 33 49 78 90 106 131
Total Income 4406 5215 6267 7300 8277 9650 11280 10609 14741 16703 19166 20601
Total Expenditure 3712 4444 5534 6549 7452 8555 9666 9427 12478 14563 16669 17725
Operating Profit 694 771 733 751 825 1095 1614 1182 2263 2140 2497 2877
Interest 119 118 180 257 295 327 533 449 379 381 449 466
Depreciation 168 212 264 314 359 396 620 573 601 615 687 719
Exceptional Income / Expenses 0 13 16 0 0 0 198 61 294 0 2 0
Profit Before Tax 407 455 332 222 171 373 660 221 1578 1144 1363 1693
Provision for Tax 102 130 97 91 112 173 225 85 477 256 446 496
Profit After Tax 305 325 235 131 60 199 435 136 1101 888 917 1197
Adjustments 12 14 -9 90 58 37 20 14 -46 -68 -18 -14
Profit After Adjustments 317 340 226 221 117 236 455 150 1056 819 899 1183
Adjusted Earnings Per Share 22.8 24.4 16.2 15.9 8.4 17 32.7 10.5 73.4 57 62.5 82.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 15% 22% 15% 16%
Operating Profit CAGR 17% 28% 18% 14%
PAT CAGR 3% 89% 36% 12%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 29% 14% 39% 20%
ROE Average 14% 17% 14% 10%
ROCE Average 19% 21% 18% 13%

Apollo Hospital Ent. Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 2977 3171 3331 3313 3252 3334 3339 4603 5623 6197 6935
Minority's Interest 19 73 78 125 132 136 131 200 280 334 385
Borrowings 1222 1728 2450 2953 2924 2952 2852 2473 2427 1938 2236
Other Non-Current Liabilities 335 410 251 1445 1499 1661 3631 3117 3815 4288 4573
Total Current Liabilities 797 1076 1250 963 1567 1955 2337 2038 2434 3325 4665
Total Liabilities 5350 6459 7360 8800 9374 10037 12290 12431 14579 16082 18794
Fixed Assets 2681 3244 3997 4583 4766 4975 7426 6773 8291 8516 9661
Other Non-Current Assets 1167 1276 1388 2087 2389 2781 2217 2016 2228 3229 3854
Total Current Assets 1501 1939 1975 2129 2220 2282 2647 3642 4061 4337 5280
Total Assets 5350 6459 7360 8800 9374 10037 12290 12431 14579 16082 18794

Apollo Hospital Ent. Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 320 274 340 335 283 306 286 381 389 546 434
Cash Flow from Operating Activities 373 470 597 623 537 905 1293 1265 1696 1377 1920
Cash Flow from Investing Activities -356 -759 -888 -1152 -405 -711 -289 -863 -847 -871 -1537
Cash Flow from Financing Activities -63 392 330 477 -108 -215 -910 -340 -792 -633 -311
Net Cash Inflow / Outflow -46 103 39 -52 24 -20 95 61 57 -127 72
Closing Cash & Cash Equivalent 274 377 379 283 306 286 381 425 547 433 506

Apollo Hospital Ent. Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 22.77 24.43 16.23 15.88 8.44 16.95 32.68 10.46 73.41 56.96 62.49
CEPS(Rs) 33.98 38.6 35.87 32 30.09 42.72 75.76 49.31 118.34 104.51 111.54
DPS(Rs) 5.75 5.75 6 6 5 6 6 3 11.75 15 16
Book NAV/Share(Rs) 213.96 227.87 238.81 237.25 233.02 238.71 239.1 319.08 389.89 424.53 469.76
Core EBITDA Margin(%) 15.34 14.19 10.95 9.74 9.6 11.05 14.06 10.73 14.9 12.34 12.54
EBIT Margin(%) 12 11.07 8.24 6.61 5.66 7.27 10.61 6.34 13.34 9.18 9.51
Pre Tax Margin(%) 9.28 8.79 5.34 3.06 2.08 3.87 5.87 2.09 10.76 6.88 7.15
PAT Margin (%) 6.96 6.28 3.79 1.81 0.72 2.07 3.87 1.29 7.51 5.34 4.81
Cash Profit Margin (%) 10.78 10.37 8.03 6.14 5.08 6.18 9.38 6.71 11.61 9.05 8.42
ROA(%) 6 5.51 3.4 1.62 0.66 2.05 3.9 1.1 8.15 5.79 5.26
ROE(%) 10.66 10.59 7.25 3.96 1.82 6.07 13.08 3.44 21.6 15.16 14.26
ROCE(%) 12.71 12.09 9.05 7.62 7.12 10.24 17.13 9.32 24.92 17.78 19.08
Receivable days 41.34 39.79 35.79 34.21 34.88 35.08 33.27 40.76 38.53 43.93 45.47
Inventory Days 20.7 22.16 22.21 21.96 22.86 21.83 21.46 17.06 8.48 9.03 8.14
Payable days 46.6 49.46 57.91 53.32 50.11 51.65 53.83 66.42 67.27 75.5 79.74
PER(x) 40.23 55.89 81.6 73.45 125.91 72.02 34.82 277.55 61.52 75.66 101.65
Price/Book(x) 4.28 5.99 5.55 4.92 4.56 5.11 4.76 9.1 11.58 10.15 13.52
Dividend Yield(%) 0.63 0.42 0.45 0.51 0.47 0.49 0.53 0.1 0.26 0.35 0.25
EV/Net Sales(x) 3.15 3.98 3.36 2.6 2.16 2.11 1.69 4.16 4.55 3.85 4.91
EV/Core EBITDA(x) 19.91 26.72 28.49 25.08 21.56 18.56 11.75 37.12 29.45 29.86 37.47
Net Sales Growth(%) 16.33 18.12 20.01 16.75 13.61 16.67 16.94 -6.11 38.85 13.3 14.73
EBIT Growth(%) 4.73 8.97 -10.66 -6.39 -2.69 49.96 70.5 -43.84 192.09 -22.09 18.85
PAT Growth(%) 3.71 6.71 -27.71 -44.26 -54.58 234.47 118.32 -68.73 709.63 -19.4 3.32
EPS Growth(%) 4.07 7.31 -33.56 -2.14 -46.87 100.88 92.75 -68 601.86 -22.4 9.71
Debt/Equity(x) 0.45 0.63 0.85 0.95 1.06 1.1 1.08 0.62 0.47 0.44 0.47
Current Ratio(x) 1.88 1.8 1.58 2.21 1.42 1.17 1.13 1.79 1.67 1.3 1.13
Quick Ratio(x) 1.53 1.48 1.25 1.73 1.06 0.87 0.82 1.66 1.49 1.19 1.03
Interest Cover(x) 4.41 4.86 2.84 1.86 1.58 2.14 2.24 1.49 5.17 4 4.03
Total Debt/Mcap(x) 0.11 0.1 0.15 0.19 0.23 0.22 0.23 0.07 0.04 0.04 0.03

Apollo Hospital Ent. Shareholding Pattern

# Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Promoter 29.33 29.33 29.33 29.33 29.33 29.33 29.33 29.33 29.33 29.33
FII 48.48 49.09 47.94 46.96 47.93 46.15 46.25 45.63 43.92 45.37
DII 15.86 15.51 16.78 17.99 17.24 18.83 19.1 19.77 21.37 20.18
Public 6.32 6.07 5.94 5.71 5.5 5.69 5.32 5.26 5.38 5.12
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 35% CAGR over last 5 years
  • Company is almost debt free.

Cons

  • Promoter holding is low: 29.33%.
  • Debtor days have increased from 75.5 to 79.74days.
  • Stock is trading at 13.9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Apollo Hospital Ent. News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!